Donor-site Morbidity After Osteochondral Autologous Transplantation for Osteochondritis Dissecans of the Capitellum: a Systematic Review and Meta-analysis
Overview
General Surgery
Orthopedics
Authors
Affiliations
Purpose: To determine the rate of donor-site morbidity after osteochondral autologous transplantation (OATS) for capitellar osteochondritis dissecans.
Methods: A literature search was performed in PubMed/MEDLINE, Embase, and Cochrane Library to identify studies up to November 6, 2016. Criteria for inclusion were OATS for capitellar osteochondritis dissecans, reported outcomes related to donor sites, ≥10 patients, ≥1 year follow-up, and written in English. Donor-site morbidity was defined as persistent symptoms (≥1 year) or cases that required subsequent intervention. Patient and harvest characteristics were described, as well as the rate of donor-site morbidity. A random effects model was used to calculate and compare weighted group proportions.
Results: Eleven studies including 190 patients were included. In eight studies, grafts were harvested from the femoral condyle, in three studies, from either the 5th or 6th costal-osteochondral junction. The average number of grafts was 2 (1-5); graft diameter ranged from 2.6 to 11 mm. In the knee-to-elbow group, donor-site morbidity was reported in 10 of 128 patients (7.8%), knee pain during activity (7.0%) and locking sensations (0.8%). In the rib-to-elbow group, one of 62 cases (1.6%) was complicated, a pneumothorax. The proportion in the knee-to-elbow group was 0.04 (95% CI 0.0-0.15), and the proportion in the rib-to-elbow group was 0.01 (95% CI 0.00-0.06). There were no significant differences between both harvest techniques (n.s.).
Conclusions: Donor-site morbidity after OATS for capitellar osteochondritis dissecans was reported in a considerable group of patients.
Level Of Evidence: Level IV, systematic review of level IV studies.
Adams B, Tran J, Voinier S, Colantonio D, Donohue M, Kilcoyne K JSES Int. 2025; 8(6):1157-1163.
PMID: 39822848 PMC: 11733562. DOI: 10.1016/j.jseint.2024.07.007.
Maeda T, Nakagawa Y, Mukai S J Orthop Case Rep. 2025; 15(1):193-196.
PMID: 39801875 PMC: 11723742. DOI: 10.13107/jocr.2025.v15.i01.5174.
Effect of Low-Level Laser Irradiation on the Proliferation of Human Chondrocytes: An In Vitro Study.
Anbari F, Khalighi H, Baharvand M, Khosousi Sani S, Sharaki M, Yadegari Z J Lasers Med Sci. 2024; 15:e55.
PMID: 39650778 PMC: 11625388. DOI: 10.34172/jlms.2024.55.
Korn P, Melnikov A, Kuhn M, Farahzadi S, Lauer G, Schroder T Head Face Med. 2024; 20(1):66.
PMID: 39478607 PMC: 11523599. DOI: 10.1186/s13005-024-00470-w.
Krakowski P, Rejniak A, Sobczyk J, Karpinski R Healthcare (Basel). 2024; 12(16).
PMID: 39201206 PMC: 11353818. DOI: 10.3390/healthcare12161648.